Main Article Content
Abstract
ABSTRACT
Objective. To describe the courses of nephrectomies performed in the urology department of the Gabriel Touré University Hospital in Bamako. Materials and methods. This was a transversal retrospective descriptive study over 03 years (January 2015 - December 2017) on patients in whom a total nephrectomy was performed in the urology department of the Gabriel Touré University Hospital in Bamako. Results. A total of 46 patients were recruited. The sex ratio was 1.09. The patients had an average age of 42.17 years with extremes from 1 year to 81 years. The reason for consultation was dominated by lumbar pain (34.8%) and lumbar masses (41.3%). The surgical indications were mainly tumor (52.2%) obstructive (478%). Extended nephrectomy was performed in 52.2% of patients. The kidney was approached anteriorly in 6.5% of cases and by lombotomy in 93.5% of cases. A drain was placed in the dressing room for an average duration of 3 days in 91% of patients. Post-operative follow-up was uneventful in 80.5% of cases. The average hospitalization duration was 9 days. Conclusion. Open radical nephrectomy is the main technique which in our contexts and it has good immediate results. Partial nephrectomy would improve the functional outcome of our patients on whom chronic diseases are frequent.
RÉSUMÉ
Objectif. Passer en revue les cas de néphrectomies réalisées dans le service d’urologie du CHU Gabriel Touré de Bamako. Matériels et méthodes. Il s’agit d’une étude transversale rétrospective descriptive étalée sur 03 ans (Janvier 2015 – décembre 2017) portant sur les patients chez qui une néphrectomie totale a été réalisée au service d’urologie du CHU Gabriel Touré de Bamako. Résultats. Nous avons recruté 46 patients. Le sex-ratio était de 1,09. Les patients avaient un âge moyen de 42,17 ans avec des extrêmes d’1 an à 81 ans. Les principaux motifs de consultation étaient les douleurs lombaires (34,8%) et les masses lombaires (41,3%). Les indications opératoires étaient tumorales (52,2%) et obstructives (478%). La néphrectomie élargie a été réalisée chez 52,2 % des patients. Le rein a été abordé par voie antérieure dans 6,5 % des cas et par lombotomie dans 93,5 % des cas. Un drain a été mis en place dans la loge pour une durée moyenne de 3 jours chez 91% des patients. Les suites post-opératoires ont été simples dans 80,5% des cas. Le délai moyen d’hospitalisation était de 9 jours. Conclusion. Malgré les progrès dans l’amélioration de sa technique, la néphrectomie reste essentiellement à ciel ouvert (laparotomie) à Bamako et elle a de bons résultats immédiats. La néphrectomie partielle, si elle est possible, améliorerait cependant le devenir fonctionnel de nos patients souvent porteurs de pathologies chroniques.
Article Details
References
- Attia Z, Azaza S, Zairi D, Kdous S, Touati S, Gritlis S. Adénopathies cervicales métastatiques d’un carcinome non retrouvé. J. TUN ORL 2013; 30: 11-5
- Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Review 2004; 30 (2): 153-64
- Benhammou A, Dib N, Nazih N, Boulaadas M, Essakali L, Kzadri M. Adenopathie cerviocales malignes en apparence primitive. La lettre du cancerologue 2008 ; XVII (9) : 446-74
- Golfinopoulos V, Pentheroudakis G, Salanti G. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Cancer Treat Rev 2009; 35: 570-3
- Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Squamous cell carcinomas metastasic to cervical lymph nodes from an unknown head and neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 2001; 50 (1): 55-63
- Grau C, Johansen LV, Jakobsen J. Cervical lymp node metastases from unknown primary tumors. Results from a national survy by the Danish Society for Head and neck Oncology. Radiother Oncol 2000; 55: 121-9
- Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003;39:1990-2005.
- Benhammou A, Dib N, Nazih N, Boulaadas N, Essakali L, Kzadri M. Adénopathies cervicales malignes en apparence primitive. La Lettre du cancérologue 2013; XVII(9):446-74
- Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head and neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 2001; 50 (1): 55-63.
- Friesland S, Lind MG, Lundgren J, Munck-Wikland E, Fernberg JO. Outcome of ipsilateral treatment for patients with metastases to neck nodes of unknown origin. Acta Oncol 2001; 40: 24-8.
- Yalin Y, Pingzhang T, Smith GH, Ilankovan V. Management and outcome of cervical lymph node metastases of unknown primary sites: a retrospective study. Br J Oral Maxillofac Surg 2002;40:484-7.
- Zeka A, Gore R, Kriebel D. Effects of alcohol and tobacco on aerodigestive cancer risks: a meta-regression analysis. Cancer Causes Control 2003;14 (9): 897-906.
- Purdue MP, Hashibe M, Berthiller J et al. Type of alcoholic beverage and risk of head and neck cancer – a pooled analysis within the INHANCE consortium. Am J Epidemiol 2009; 169 (2): 132-42.
- Auperin A, Melkane A, Luce D, Temam S. Epidémiologie des cancers des voies aéro-digestives supérieures. La Lettre du cancérologue 2011; XX (2): 102-6
- Institut de veille sanitaire (ministère de la Santé en France): www.invs.sante.fr/surveillance/cancers
- Benderra MA, Ilie M, Hofman P, Massard C. Standard of care of carcinomas on cancer of unknown primary site in 2016. Bull Cancer 2016; 103: 697-705.
- Gonne E, Collignon J, Jerusalem G, Gennigens C. Le carcinome de site primitif inconnu, une entité pas si rare. Rev Med Liege 2016; 71 (10): 449-54
- Rosenthal DI, Liu L, Lee JH et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 2002; 24: 115-26.
References
Attia Z, Azaza S, Zairi D, Kdous S, Touati S, Gritlis S. Adénopathies cervicales métastatiques d’un carcinome non retrouvé. J. TUN ORL 2013; 30: 11-5
Jereczek-Fossa BA, Jassem J, Orecchia R. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary. Cancer Treat Review 2004; 30 (2): 153-64
Benhammou A, Dib N, Nazih N, Boulaadas M, Essakali L, Kzadri M. Adenopathie cerviocales malignes en apparence primitive. La lettre du cancerologue 2008 ; XVII (9) : 446-74
Golfinopoulos V, Pentheroudakis G, Salanti G. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Cancer Treat Rev 2009; 35: 570-3
Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Squamous cell carcinomas metastasic to cervical lymph nodes from an unknown head and neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 2001; 50 (1): 55-63
Grau C, Johansen LV, Jakobsen J. Cervical lymp node metastases from unknown primary tumors. Results from a national survy by the Danish Society for Head and neck Oncology. Radiother Oncol 2000; 55: 121-9
Pavlidis N, Briasoulis E, Hainsworth J, Greco FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003;39:1990-2005.
Benhammou A, Dib N, Nazih N, Boulaadas N, Essakali L, Kzadri M. Adénopathies cervicales malignes en apparence primitive. La Lettre du cancérologue 2013; XVII(9):446-74
Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head and neck mucosal site treated with radiation therapy alone or in combination with neck dissection. Int J Radiat Oncol Biol Phys 2001; 50 (1): 55-63.
Friesland S, Lind MG, Lundgren J, Munck-Wikland E, Fernberg JO. Outcome of ipsilateral treatment for patients with metastases to neck nodes of unknown origin. Acta Oncol 2001; 40: 24-8.
Yalin Y, Pingzhang T, Smith GH, Ilankovan V. Management and outcome of cervical lymph node metastases of unknown primary sites: a retrospective study. Br J Oral Maxillofac Surg 2002;40:484-7.
Zeka A, Gore R, Kriebel D. Effects of alcohol and tobacco on aerodigestive cancer risks: a meta-regression analysis. Cancer Causes Control 2003;14 (9): 897-906.
Purdue MP, Hashibe M, Berthiller J et al. Type of alcoholic beverage and risk of head and neck cancer – a pooled analysis within the INHANCE consortium. Am J Epidemiol 2009; 169 (2): 132-42.
Auperin A, Melkane A, Luce D, Temam S. Epidémiologie des cancers des voies aéro-digestives supérieures. La Lettre du cancérologue 2011; XX (2): 102-6
Institut de veille sanitaire (ministère de la Santé en France): www.invs.sante.fr/surveillance/cancers
Benderra MA, Ilie M, Hofman P, Massard C. Standard of care of carcinomas on cancer of unknown primary site in 2016. Bull Cancer 2016; 103: 697-705.
Gonne E, Collignon J, Jerusalem G, Gennigens C. Le carcinome de site primitif inconnu, une entité pas si rare. Rev Med Liege 2016; 71 (10): 449-54
Rosenthal DI, Liu L, Lee JH et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 2002; 24: 115-26.